Your browser doesn't support javascript.
loading
Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease Model.
Passman, Adam M; Strauss, Robyn P; McSpadden, Sarah B; Finch-Edmondson, Megan; Andrewartha, Neil; Woo, Ken H; Diepeveen, Luke A; Zhao, Weihao; Fernández-Irigoyen, Joaquín; Santamaría, Enrique; Medina-Ruiz, Laura; Szpakowska, Martyna; Chevigné, Andy; Park, Hyerin; Carlessi, Rodrigo; Tirnitz-Parker, Janina E E; Blanco, José R; London, Roslyn; Callus, Bernard A; Elsegood, Caryn L; Baker, Murray V; Martínez, Alfredo; Yeoh, George C T; Ochoa-Callejero, Laura.
Afiliação
  • Passman AM; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Strauss RP; Centre for Medical Research, Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
  • McSpadden SB; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Finch-Edmondson M; Centre for Medical Research, Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
  • Andrewartha N; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Woo KH; Centre for Medical Research, Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
  • Diepeveen LA; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Zhao W; Centre for Medical Research, Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
  • Fernández-Irigoyen J; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Santamaría E; Centre for Medical Research, Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
  • Medina-Ruiz L; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Szpakowska M; Centre for Medical Research, Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
  • Chevigné A; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Park H; Centre for Medical Research, Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
  • Carlessi R; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Tirnitz-Parker JEE; Proteored-ISCIII, Proteomics Platform, Navarrabiomed, Navarra Health Department, Navarra Institute for Health Research (IdiSNA), Public University of Navarra, 31008 Pamplona, Spain.
  • Blanco JR; Proteored-ISCIII, Proteomics Platform, Navarrabiomed, Navarra Health Department, Navarra Institute for Health Research (IdiSNA), Public University of Navarra, 31008 Pamplona, Spain.
  • London R; Institute of Infection, Immunity and Inflammation, Glasgow Biomedical Research Center, University of Glasgow, Glasgow G12 8TA, UK.
  • Callus BA; Immuno-Pharmacology and Interactomics Department of Infection and Immunity, Luxembourg Institute of Health, 4354 Esch-sur-Alzette, Luxembourg.
  • Elsegood CL; Immuno-Pharmacology and Interactomics Department of Infection and Immunity, Luxembourg Institute of Health, 4354 Esch-sur-Alzette, Luxembourg.
  • Baker MV; Centre for Medical Research, Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.
  • Martínez A; UWA Medical School, University of Western Australia, Crawley, WA 6009, Australia.
  • Yeoh GCT; Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Bentley, WA 6102, Australia.
  • Ochoa-Callejero L; Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Bentley, WA 6102, Australia.
Cancers (Basel) ; 13(19)2021 Sep 30.
Article em En | MEDLINE | ID: mdl-34638423

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália